PanVenture China Consulting - Business and Financial Advisory

PanVenture is a BVI (British Virgin Islands) company that was established in 2000. PanVenture’s main business activities are investment and financial advisory services and we are specialists in China strategy. We provide services across a broad range of industries including Education, Infrastructure, Transport and Technology. PanVenture advises foreign companies and education institutions on cooperating and investing in China, and also advises Chinese companies in the IPO process to access the foreign exchange markets in London and New York. PanVenture has offices in Beijing, San Francisco and London. PanVenture is in the process of investigating the strengths and opportunities of several new markets and investment opportunities, and plans to establish new offices in Shandong Province this year.

"To act as a bridge between Europe, America and China to fuel the cross-development of Infrastructure, Education, Culture and Business"

Since its founding PanVenture has provided advisory services critical to the international business development, operations management, and financing of foreign entities in China, Taiwan, USA and UK. PanVenture has provided solid business advisory services to prestigious entities including British and American Universities, Government Agencies, and Global Companies. PanVenture has successfully located funding, licensing, technology transfer, manufacturing, and distribution partners for its clients. PanVenture has also made private placements for emerging technology companies from the IC design, wireless communications, MEMS-based sensor, nanotechnology, healthcare and bioinformatics industries. A list of engagements and satisfied customers is available under confidentiality upon request.

PanVenture's goals are to: (1) to contribute as much as possible to the development of China's infrastructure through participation in Education, Energy, Environment, and Healthcare related projects; (2) to assist educational institutions, companies and government agencies with developing their China entry strategy and implementation plans; (3) to provide a springboard for small and medium companies into these markets through strategic alliances and introduce American, European and Asian clients to develop manufacturing, product development, technology transfer, licensing and investment partnerships and to act as a long-term valuable intelligence and operational resource for our clients as they grow to IPO and beyond; (4) to develop international collaborative business opportunities in the Life Sciences, Biotech, Pharma, Hi-Tech, Optronics and Telecom industries.

PanVenture's team of experienced professionals bring together a formidable depth and breadth of technical, management and financial expertise, a proven track record and the required relationships with an extensive investor network across the three continents. PanVenture has established strong alliances with Venture Capital Funds and Investment Banks in Asia, Europe and USA, and has local political and industry network in the countries in which it operates.

Dr. Christopher Bayley, President and CEO of PanVenture founded the company in 2000 in order to provide business strategy and financial consulting services to international clients in order to facilitate more efficient integration of their American, European and Chinese business operations. With PanVenture, Chris has held interim Senior Management positions in top level organizations including the UK University of Nottingham - Ningbo Campus in Zhejiang Province, and Linuo Group in Jinan, Shandong Province. Prior to founding PanVenture, from 1997 to 2000, Chris was a Regional Director for KPMG Asia-Pacific (Peat Marwick). Chris was the CKO for all of KPMG's Asia-Pacific 127 offices located in 27 countries. From 1995 to 1997, Chris was Vice President of Marketing for Panorama Research Inc, and from 1992 to 1995 was Director of Business Development for ImmuDyne, Inc., both located in Palo Alto, California, USA with a focus on marketing to Asia and Europe. Prior to 1992, Chris worked with a number of start-up biotech and internet technology companies in the SF Bay Area in business development and consulting roles. Chris also taught as an Adjunct Professor at Santa Clara University, and held Post-Doctoral Fellowships with the MAFF (Tsukuba, Japan), the USDA (Berkeley, California), and DuPont R&D (Wilmington, Delaware). Chris received his MBA in International Marketing from Santa Clara University, California, USA in 1993, his PhD in Biotechnology in 1987 and a BSc in Genetics and Biochemistry in 1983, both from the University of Nottingham in the UK. Chris has a number of publications in peer-reviewed scientific journals including "Nature" and speaks Chinese.

Jim Larrick played a major role in the foundation of PanVenture, and is a Senior Advisor based in Palo Alto California. Jim provides the support and infrastructure for PanVenture's North American operations. Jim's role also includes assistance in technology transfer and due diligence expertise as well as access to numerous angel investors and global venture capital networks. Jim is the President and Chairman of numerous corporations including Panorama Research Institute and PanGenetics (recently merged with TANOX). Jim also acts as the co-chair on the biotech screening committee of TENEX Medical angel investors in the SF Bay Area (see PanVenture’s partnerships link ). Larrick has published a number of books on the subject of immunology, cancer, gene therapy and cloning, with several hundred peer-reviewed scientific publications and is on the editorial board of at least 8 prestigious journals. Jim has outstanding track records both as a research pioneer and as a successful entrepreneur.

Robert Applegate

Robert Applegate is Director of Business Development for PanVenture Americas Region, and handles operations, business and legal issues concerning American client companies starting or expanding into China. Robert has a B.A. in Asian Studies from the University of Texas and a J.D. degree from Pace University School of Law in New York. In the early 1980's he handled foreign accounts for Taiwan's oldest public relations firm, United Pacific International. His legal positions include working for the City Attorney's Of f ice in Houston, the London office of Otis Elevator, UPS's corporate headquarters in Connecticut and for EDO Corporation in New York City. In 1995 Robert was a co-organiser of the first international conference for US companies interested in marketing to China. Many Fortune 500 companies, the US Department of Commerce, the FDA and their Chinese counterparts all participated in this ground breaking event. In 1997, Robert co-created together with UCSD's Connect Program a conference entitled ''China's Medical Market: Opportunities for U.S. Biotechnology, Medical Equipment, and Pharmaceutical Companies.'' He was also the co-creator of the ''Exporting Medical Devices to Europe & China'' conference in 1999 with the San Diego World Trade Center and the U.S. Department of Commerce. In 1998 he was nominated Chairman of the China Workshops for the Medical Design and Manufacturing West conference and exhibition in Anaheim.

Jimmy Richardson acts a Senior Advisor to PanVenture with a focus on its European operations. Jimmy has more than three decades of international experience in accountancy, legal, tax advisory and management consulting roles for prestigious firms. Jimmy provides management and financial expertise to assist clients: (a) to establish tax efficient international corporate structures; and (b) to develop operating and supply chain strategies to minimize costs and maximize profitability. This applies in particular to engineering or technology-based firms with cross-border manufacturing, assembly, and distribution channels.

Trevor Bayley acts a Senior Advisor to PanVenture with a focus on its European and China operations. Trevor is also Senior Partner of TB Associates Co. Ltd, PanVenture's strategic partner in Kent, UK. Trevor has more than twenty years of international experience in tax advisory, business and accounting consultancy, software development, system integration and project management roles for small and medium enterprises. Trevor provides project management and financial technical expertise to assist clients with international challenges to develop efficient business and financial systems. Trevor is a certified member of the British ATT (Assocation of Tax Technicians) and also has Microsoft Certification credentials from the USA.

Based in China, Kent assists PanVenture with business development and strategy in China. Kent is a Partner at Temima Group (China) and has been involved in the investment banking industry in China and Taiwan for more than 8 years. Kent was also one of the founders of 3Together, a Taiwanese venture capital firm and was a former director for Inter Asia Investment and Yu-Chen Fund Management. Kent received a BA in Finance from the University of Southern California in 1994.

Katie Wang, based in Jinan and Beijing, assists PanVenture with business development services to our Chinese clients and also helps to deliver China services to PanVenture's US and European clients. Katie is also Managing Director of Jinan Yihong International Management Consulting Group, PanVenture's strategic partner in Jinan, China. Katie trained and worked as an Investment Consultant at Qilu Futures Co, Ltd., and has also held consulting positions in many companies, including Zhongtai Daily Chemicals Co, Ltd. (Hong Kong owned). Miss Wang received her Master’s Degree in Management Economics (with honors) in 2004 from the University of Essex in the UK, and a Bachelor’s Degree in Economics and Finance from Shandong Finance Institute in China in 2002.

Fred Sen is based in Taiwan and provides PanVenture with valuable local expertise in technology transfer, business development, sales and distribution, and private placement in Taiwan. Fred has over a decade of experience in the investment banking and venture capital industries and has strong expertise in the IC design, telecom, wireless and internet technologies. Fred has had a highly successful track record in investment management and is an expert in due diligence and his portfolio management experience includes embedded linux solutions, MPEG decode/encode chip, DWDM optical fiber components, smart antennas, radio-defined equipment, multimode base station controller, network core switch, MIPS processor technologies. Fred is also a partner at Garagefund.com which invests in high-tech startup companies. Prior to raising this fund, Fred was General Manager of Global Impex Enterprise which he helped to raise from US and Taiwan investors, and focusing on early and expansion stage US based high-tech companies. Fred has also held consulting positions in the US including with Stream Machine Corporation, Bayspec Corporation, and China Development Bank, New Dimension Research, Inc and Vweb Corporation. Fred received a Mechanical Engineering degree from the Southern Engineering College in 1987 and a post-graduate degree from the Investment Banking Taipei Foundation of Finance in 1996.

Stephen Chang acts in an advisory role to PanVenture both on Asian business development and corporate finance. Mr. Chang received his Masters in Law and Economics (London, UK). Stephen was formerly a consultant with Andersen Consulting in Taiwan in their corporate finance group, and prior to that he was employed by PriceWaterhouseCoopers in New York. Stephen also has significant experience as a trader of Asian stock portfolios.

On June 1st, 2004 PanVenture entered into a strategic partnership agreement with "Jinan Yihong International" Management Consulting Firm, a consulting company that assists Chinese clients to "Internationalize" their operations. Core services include developing contracts with American and European customers, suppliers, technology partners, joint venture partners, distribution partners and that require OEM or manufacturing in China.

In November, 2003, PanVenture established a strategic partnership with TCIB, (Temima China Investment Bank), and its UK parent company "Temima Group". Through this strategic partnership, PanVenture is now offering an expanded range of services to its Chinese clients, including cross-border M&A and international IPO listing services.

Sinova Capital is a private investment bank which has cooperated with PanVenture on Nasdaq Listing cases since 2004. Sinova Capital has been operating since 1987 and has offices in Seattle, San Francisco, and London.

BroadMark Capital is a private investment bank which has cooperated with PanVenture on numerous technology transfer and fund-raising cases since 1999. Broadmark Capital has been operating since 1987 and has offices in Seattle, New York, and Chicago. Broadmark has two divisions - Corporate Finance and Capital Markets and provides Investment, Advisory and Financing services. Broadmark's strategy is to leverage its two divisions to provide "smart money". Broadmark's investmenmt focus is: communications and networking/Internet services, biotech, healthcare and medical devices. They have typically achieved 2-3 IPOs a year and placed US $200 Million in private equity financing since 1998.

West Sussex Trading (with offices in Boston) – has cooperated with PanVenture on several technology transfer and fund-raising cases since 1999. West Sussex Trading has been operating since 1996, having successfully raised funds and incubated the following companies: (1) US$16 Million - SmarTire Systems Inc (Nasdaq SMTR); (2) US$1.5 Million - The RiceX Company (Nasdaq RICX); (3) US$13 Million - ICOMS - Co-invested with Lycos; (4) US$6 Million - Iglu; (5) US$6 Million - Molecularware.

TripleTree (with offices in Minneapolis, New York, Los Angeles) - has cooperated with PanVenture on US-based out-licensing and fund-raising in Asia since 2001. TripleTree is one of the leading IT and Life Sciences Investment Institutions in the USA, manages several funds and has multiple investment channels through strong partnerships with other US Investment Groups. TripleTree provides advisory, private placement and M&A services, and their portfolio clients are mainly IT and Life Sciences. TripleTree frequently publishes industry sector and technology focused research reports.

TENEX Medical is a group of over 200 Angels in the Bay Area, California, which has cooperated with PanVenture on numerous technology transfer and fund-raising cases since 1993. Each of these Angel Investors are outstanding achievers in their own field of expertise, and each can leverage their own network of connections in industry, finance and research. TENEX Medical has several years of operating history, and their members hold bi-weekly investment meetings. Their typical focus is on Drug Discovery, Biotech, Bio-informatics, E-Health, and collectively they will invest between US$250,000 and US$2 million, with a strong track record of selecting successful businesses.